These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9155694)

  • 1. Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells.
    Sohda T; Oka Y; Iwata K; Gunn J; Kamimura S; Shijo H; Okumura M; Yun K
    J Clin Pathol; 1997 Feb; 50(2):135-7. PubMed ID: 9155694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
    World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
    Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
    Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: relationship to fatty change in carcinoma cells.
    Sohda T; Kamimura S; Iwata K; Shijo H; Okumura M
    J Gastroenterol Hepatol; 1997 Mar; 12(3):224-8. PubMed ID: 9142639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immunohistochemical study.
    Fiorentino M; Grigioni WF; Baccarini P; D'Errico A; De Mitri MS; Pisi E; Mancini AM
    Diagn Mol Pathol; 1994 Mar; 3(1):59-65. PubMed ID: 8162257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium.
    Adesanya OO; Zhou J; Bondy CA
    J Clin Endocrinol Metab; 1996 May; 81(5):1967-74. PubMed ID: 8626866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
    Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
    Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
    Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry.
    Yang DY; Rogler CE
    Carcinogenesis; 1991 Oct; 12(10):1893-901. PubMed ID: 1657428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.
    Qian J; Yao D; Dong Z; Wu W; Qiu L; Yao N; Li S; Bian Y; Wang Z; Shi G
    Am J Clin Pathol; 2010 Nov; 134(5):799-806. PubMed ID: 20959664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis].
    Fan Z; Yang D; Qin H
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas.
    Nordqvist AC; Peyrard M; Pettersson H; Mathiesen T; Collins VP; Dumanski JP; Schalling M
    Cancer Res; 1997 Jul; 57(13):2611-4. PubMed ID: 9205065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis.
    Cariani E; Seurin D; Lasserre C; Franco D; Binoux M; Brechot C
    J Hepatol; 1990 Sep; 11(2):226-31. PubMed ID: 2174934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis].
    Dong ZZ; Yao M; Qian J; Yan XD; Chen J; Yan MJ; Yao NH; Yao DF
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):892-6. PubMed ID: 23863671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas.
    Lamas E; Le Bail B; Housset C; Boucher O; Bréchot C
    Lab Invest; 1991 Jan; 64(1):98-104. PubMed ID: 1846656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity.
    Bae MH; Lee MJ; Bae SK; Lee OH; Lee YM; Park BC; Kim KW
    Cancer Lett; 1998 Jun; 128(1):41-6. PubMed ID: 9652791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.